
Biotechnology
Google’s AI Drug Startup Isomorphic Labs Raises $600M
Isomorphic Labs, the artificial intelligence-driven drug discovery startup spun out of DeepMind, has secured $600 million in its first-ever external funding round. The financing, led by Thrive Capital with participation from Alphabet and its venture arm GV, marks a significant milestone for the Alphabet-owned company as it scales its efforts